By Monica P. Mallampalli, PhD Tirzepatide has gained attention as a promising treatment for moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity. However, the rise of compounded tirzepatide products has raised serious concerns for patient safety. Patients and healthcare providers must understand the risks involved with compounded versions of this medication to avoid potential harm to patients. What Is Tirzepatide and Why Is It Important? Tirzepatide is a pr

About half of patients abandon CPAP therapy. It’s time to embrace a patient-centered approach with a wider range of treatment options,...